JIUZHITANG CO.,LTD — Investor Relations & Filings
JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度分红派息实施公告 | 2026-05-06 | Chinese | |
| 独立董事述职报告（张劲松） | 2026-03-26 | Chinese | |
| 关于召开2025年度业绩说明会并征集问题的公告 | 2026-03-26 | Chinese | |
| 2025年度内部控制自我评价报告 | 2026-03-26 | Chinese | |
| 九芝堂股份有限公司舆情管理制度 | 2026-03-26 | Chinese | |
| 2025年年度报告摘要 | 2026-03-26 | Chinese |
Browse filings by year
26 years- 2026 27 filings
- 2025 83 filings
- 2024 131 filings
- 2023 65 filings
- 2022 97 filings
- 2021 74 filings
- 2020 122 filings
- 2019 88 filings
- 2018 118 filings
- 2017 117 filings
- 2016 95 filings
- 2015 145 filings
- 2014 96 filings
- 2013 53 filings
- 2012 66 filings
- 2011 58 filings
- 2010 46 filings
- 2009 36 filings
- 2008 66 filings
- 2007 74 filings
- 2006 83 filings
- 2005 37 filings
- 2004 35 filings
- 2003 43 filings
- 2002 23 filings
- 2001 7 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44279349 | 2025年度分红派息实施公告 | 2026-05-06 | Chinese | ||
| 44286286 | 独立董事述职报告（张劲松） | 2026-03-26 | Chinese | ||
| 44286271 | 关于召开2025年度业绩说明会并征集问题的公告 | 2026-03-26 | Chinese | ||
| 44286258 | 2025年度内部控制自我评价报告 | 2026-03-26 | Chinese | ||
| 44286249 | 九芝堂股份有限公司舆情管理制度 | 2026-03-26 | Chinese | ||
| 44286197 | 2025年年度报告摘要 | 2026-03-26 | Chinese | ||
| 44286194 | 董事会关于2025年度委托理财情况的专项说明 | 2026-03-26 | Chinese | ||
| 44286180 | 第九届董事会独立董事专门会议第三次会议决议公告 | 2026-03-26 | Chinese | ||
| 44286179 | 2025年度内部控制审计报告 | 2026-03-26 | Chinese | ||
| 44286153 | 九芝堂股份有限公司关联交易管理制度 | 2026-03-26 | Chinese | ||
| 44286133 | 九芝堂股份有限公司信息披露暂缓与豁免管理制度 | 2026-03-26 | Chinese | ||
| 44286120 | 九芝堂股份有限公司董事会议事规则（2026年3月修正草案） | 2026-03-26 | Chinese | ||
| 44286108 | 九芝堂股份有限公司董事会战略委员会实施细则 | 2026-03-26 | Chinese | ||
| 44286095 | 九芝堂股份有限公司董事、高级管理人员离职管理制度 | 2026-03-26 | Chinese | ||
| 44286074 | 九芝堂股份有限公司董事、高级管理人员薪酬管理制度（2026年3月草案） | 2026-03-26 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
JIUZHITANG CO.,LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53946/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53946 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53946 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53946 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53946}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for JIUZHITANG CO.,LTD (id: 53946)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.